CJ Bioscience (311690.KQ) Stock Price

CJ Bioscience Price

CLOSED
3,845.00
​
Market closed

Revenue has compounded at 0.1% per year over the past 8 years to 3.69 B KRW. CJ Bioscience's net margin stands at -650.1%, down from -441.7% several years earlier.

CJ Bioscience stock price

Access this data via the Eulerpool API

CJ Bioscience business model & stock analysis

CJ Bioscience, Inc. engages in the research and development of biotechnology and in the provision of solutions for microbiological researches including biomedicine, institutional research and development and genetic sequencing. The company is headquartered in Seoul, Seoul. The company went IPO on 2019-12-26. The firm mainly provides microbial bioinformatics analysis services and microbiome-based healthcare services through bioinformatics database and cloud analytics platform. The firm also develops microbiome therapies and infection diagnosis solutions.

Frequently asked questions about CJ Bioscience

Converted at the current exchange rate, the CJ Bioscience share trades at 2.56 EUR (3,845.00 KRW).

The revenue cannot currently be calculated for CJ Bioscience.

The profit cannot currently be calculated for CJ Bioscience.

The P/E ratio cannot be calculated for CJ Bioscience at the moment.

The P/S cannot be calculated for CJ Bioscience currently.

The Eulerpool Quality Score for CJ Bioscience is 2/10.

The ISIN of CJ Bioscience is KR7311690002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of CJ Bioscience is 311690.KQ. The ticker symbol is used to trade CJ Bioscience shares on the stock exchange.

Fair ValueTerminal
3,191.35 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Dec 26, 2019
ISIN
KR7311690002
Cusip
Y1R288102
Market capitalization
35.66 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
0.66
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-44.75 %
Last updated Oct 9, 2026, 7:20 AM

CJ Bioscience Peer Group

CJ Bioscience FIGI

311690:KS · BBG00QXV4WC9311690:KQ · BBG00QXV4WF6